EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+6.51%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.95B
AUM Growth
+$137M
(+7.6%)
Cap. Flow
+$70.7M
Cap. Flow
% of AUM
3.63%
Top 10 Holdings %
Top 10 Hldgs %
62.7%
Holding
375
New
57
Increased
197
Reduced
86
Closed
22
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Microsoft
MSFT
|
$12.2M |
| 3 |
NVIDIA
NVDA
|
$9.41M |
| 4 |
Broadcom
AVGO
|
$6.49M |
| 5 |
Pinduoduo
PDD
|
$5.98M |
Top Sells
| 1 |
ASE Group
ASX
|
$18.3M |
| 2 |
Sea Limited
SE
|
$11.3M |
| 3 |
TSMC
TSM
|
$9.44M |
| 4 |
ZTO Express
ZTO
|
$7.08M |
| 5 |
NIO
NIO
|
$4.53M |
Sector Composition
| 1 | Consumer Discretionary | 37.74% |
| 2 | Technology | 30.94% |
| 3 | Communication Services | 8.5% |
| 4 | Healthcare | 6.31% |
| 5 | Financials | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Fate Therapeutics
FATE
$116M
| $1.24M | 0.06% |
353,771
-1,454
| -0.4% | -$5.09K |
|
127
Idexx Laboratories
IDXX
$51.4B
| $1.23M | 0.06% |
2,434
+1,101
| +83% | +$556K |
|
128
Automatic Data Processing
ADP
$120B
| $1.22M | 0.06% |
4,417
+306
| +7% | +$84.7K |
|
129
Airbnb
ABNB
$75.8B
| $1.2M | 0.06% |
9,471
+4,002
| +73% | +$507K |
|
130
Gartner
IT
$18.6B
| $1.2M | 0.06% |
2,364
+1,250
| +112% | +$633K |
|
131
Starbucks
SBUX
$97.1B
| $1.19M | 0.06% |
12,236
+889
| +8% | +$86.7K |
|
132
United Therapeutics
UTHR
$18.1B
| $1.15M | 0.06% |
3,204
-704
| -18% | -$252K |
|
133
Amphenol
APH
$135B
| $1.13M | 0.06% |
17,405
-11,527
| -40% | -$751K |
|
134
Exact Sciences
EXAS
$10.2B
| $1.13M | 0.06% |
16,576
-10,303
| -38% | -$702K |
|
135
Natera
NTRA
$23.1B
| $1.09M | 0.06% |
8,587
-1,392
| -14% | -$177K |
|
136
Sarepta Therapeutics
SRPT
$1.96B
| $1.09M | 0.06% |
8,716
-45
| -0.5% | -$5.62K |
|
137
Palantir
PLTR
$363B
| $1.08M | 0.06% |
+29,063
| New | +$1.08M |
|
138
Mondelez International
MDLZ
$79.9B
| $1.07M | 0.05% |
14,467
+619
| +4% | +$45.6K |
|
139
Insmed
INSM
$30.7B
| $1.06M | 0.05% |
14,551
+7,736
| +114% | +$565K |
|
140
Monster Beverage
MNST
$61B
| $1.04M | 0.05% |
19,960
+9,965
| +100% | +$520K |
|
141
Viking Therapeutics
VKTX
$3.03B
| $1.03M | 0.05% |
16,280
-4,100
| -20% | -$260K |
|
142
Deckers Outdoor
DECK
$17.9B
| $1.03M | 0.05% |
6,460
-12,530
| -66% | -$2M |
|
143
S&P Global
SPGI
$164B
| $1.03M | 0.05% |
1,991
+236
| +13% | +$122K |
|
144
Neurocrine Biosciences
NBIX
$14.3B
| $1.02M | 0.05% |
8,887
+1,568
| +21% | +$181K |
|
145
Microchip Technology
MCHP
$35.6B
| $1.01M | 0.05% |
12,614
+1,771
| +16% | +$142K |
|
146
Carnival Corp
CCL
$42.8B
| $999K | 0.05% |
54,076
+27,038
| +100% | +$500K |
|
147
RH
RH
$4.7B
| $995K | 0.05% |
2,974
+395
| +15% | +$132K |
|
148
IQVIA
IQV
$31.9B
| $994K | 0.05% |
4,193
+3,106
| +286% | +$736K |
|
149
GE Vernova
GEV
$158B
| $953K | 0.05% |
+3,739
| New | +$953K |
|
150
Kyverna Therapeutics
KYTX
$170M
| $926K | 0.05% |
189,432
| – | – |
|